Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results

Go back to Praxis Precision Medicines Provides Corporate Update and Reports First Quarter 2026 Financial Results
(NASDAQ: PRAX) Delayed: 266.58 +18.60 (7.50%)
Previous Close $247.98    52 Week High
Open $247.26    52 Week Low
Day High $269.40    P/E N/A 
Day Low $247.26    EPS
Volume 423,174